Patents by Inventor Deepak B. Mundhra

Deepak B. Mundhra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions
    Patent number: 11224597
    Abstract: The present Invention relates to pharmaceutical compositions of (3S,11aR)—N-[(2,4-difluorophenyhmethyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: January 18, 2022
    Assignee: ViiV Healthcare Company
    Inventors: Deepak B. Mundhra, Rennan Pan
  • Pharmaceutical Compositions
    Publication number: 20170027933
    Abstract: The present Invention relates to pharmaceutical compositions of (3S,11aR)—N-[(2,4-difluorophenyhmethyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
    Type: Application
    Filed: October 13, 2016
    Publication date: February 2, 2017
    Inventors: Deepak B. MUNDHRA, Rennan PAN
  • Pharmaceutical Compositions
    Publication number: 20130171214
    Abstract: The present Invention relates to pharmaceutical compositions of (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
    Type: Application
    Filed: September 15, 2011
    Publication date: July 4, 2013
    Applicant: VIIV Healthcare Company
    Inventors: Deepak B. Mundhra, Rennan Pan